Your browser doesn't support javascript.
loading
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.
Uldrick, Thomas S; Gonçalves, Priscila H; Wyvill, Kathleen M; Peer, Cody J; Bernstein, Wendy; Aleman, Karen; Polizzotto, Mark N; Venzon, David; Steinberg, Seth M; Marshall, Vickie; Whitby, Denise; Little, Richard F; Wright, John J; Rudek, Michelle A; Figg, William D; Yarchoan, Robert.
Afiliação
  • Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA uldrickts@mail.nih.gov.
  • Gonçalves PH; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Wyvill KM; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Peer CJ; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA.
  • Bernstein W; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Aleman K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Polizzotto MN; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Venzon D; Biostatistics and Data Management Section at the Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Steinberg SM; Biostatistics and Data Management Section at the Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Marshall V; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Little RF; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Wright JJ; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
  • Rudek MA; Analytical Pharmacology Core, Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Figg WD; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA.
  • Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
Oncologist ; 22(5): 505-e49, 2017 05.
Article em En | MEDLINE | ID: mdl-28341759
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Sarcoma de Kaposi / Niacinamida / Ritonavir / Citocromo P-450 CYP3A Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Humans / Male / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Sarcoma de Kaposi / Niacinamida / Ritonavir / Citocromo P-450 CYP3A Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Humans / Male / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos